Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal - WSJ — RatedNews

Wall Street Journal

US · 6 hrs ago

Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal - WSJ

—Quality

0Ratings

0Comments

🔒news.google.com

Opens in app

Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal - WSJ

Wall Street Journal · 6 hrs ago

Eli Lilly, Ascidian Sign $1.9 Billion Kidney-Disease Treatment Deal WSJ

Discussion 0 comments

Sort:

?

No comments yet — be the first to start the discussion!